Inoperable early stage non-small cell lung cancer: Comorbidity, patterns of care and survival

Lung Cancer

Volumn 72, Issue 1, 2011, Pages 39-44

  Smith, S L ^a   Palma, D ^a,b   Parhar, T ^a   Alexander, C S ^a   Wai, E S ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Charlson comorbidity index; Early stage; Inoperable; Non small cell lung cancer; Palliative care; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; SCORING SYSTEM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 79952194078     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.07.015     Document Type: Article

References (32)

1. Wisnivesky J.P., Bonomi M., Henschke C., Iannuzzi M., McGinn T. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 2005, 128:1461-1467.
2. Qiao X., Tullgren O., Lax I., Sirzon F., Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003, 41:1-11.
3. Zimmermann F.B., Bamberg M., Molls M., Jeremic B. Radiation therapy alone in early stage non-small cell lung cancer. Semin Surg Oncol 2003, 21:91-97.
4. Slotman B.J., Hian Njo K., Karim A.B.M.F. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1994, 29:33-37.
5. Sibley M.D., Jamieson M.D., Marks M.D., Anscher M.D., Prosnitz M.D. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998, 40:149-154.
6. Rowell N.P., Williams C.J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 2001, 56:628-638.
7. Gauden S.J., Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer 2001, 32:71-79.
8. National Comprehensive Cancer Network Clinical Practice Guideline: Non-Small Cell Lung Cancer. 10-3-2010. Ref Type: Electronic Citation. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf.
9. BC Cancer Agency Cancer Management Guidelines. 10-3-2010. Ref Type: Electronic Citation. http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/default.htm.
10. Vrdoljak E., Mise K., Sapunar D., Rozga A., Marusic M. Survival analysis of untreated patients with non-small-cell lung cancer. Chest 1994, 106:1797-1800.
11. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989, 62:679-694.
12. Cheung P.C., Mackillop W.J., Dixon P., Brundage M.D., Youssef Y.M., Zhou S. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2000, 48:703-710.
13. Charlson M.E., Pompei P., Ales K.L., Mackenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
14. Koppie T.M., Serio A.M., Vickers A.J., Vora K., Dalbagni G., Donat S.M., et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008, 112:2384-2392.
15. Fairchild A., Harris K., Barnes E., Wong R., Lutz S., Bezjak A., et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 2008, 26:4001-4011.
16. McGarry R.C., Song G., des Rosiers P., Timmerman R. Observation-only management of early stage, medically inoperable lung cancer. Chest 2002, 121:1155-1158.
17. Palma D., Tyldesley S., Sheehan F., Mohamed I., Smith S., Wai E., et al. Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and above: does age determine survival after radical treatment? J Thorac Oncol 2010, 5:818-824.
18. Kyasa M.J., Jazieh A.R. Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer. South Med J 2002, 95:1149-1152.
19. Wisnivesky J.P., Halm E., Bonomi M., Powell C., Bagiella E. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med 2010, 181:264-269.
20. Powell J.W., Dexter E., Scalzetti E.M., Bogart J.A. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol 2009, 10:885-894.
21. Dahele M., Brade A., Pearson S., Bezjak A. Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer. CMAJ 2009, 180:1326-1328.
22. Haasbeek C.J.A., Senan S., Smit E.F., Paul M.A., Slotman B.J., Lagerwaard F.J. Critical review of nonsurgical treatment options for stage I non-small cell lung cancer. Oncologist 2008, 13:309-319.
23. Lagerwaard F.J., Haasbeek C.J.A., Smit E.F., Slotman B.J., Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692.
24. Nguyen N.P., Garland L., Welsh J., Hamilton R., Cohen D., Vinh-Hung V. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. Cancer Treat Rev 2008, 34:719-727.
25. Grills I.S., Mangona V.S., Welsh R., Chmielewski G., McInerney E., Martin S., et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010, 28:928-935.
26. Palma D.A., Visser O., Lagerwaard F.J., Senan S. Treatment utilization and survival for elderly patients with stage I NSCLC: a population-based time-trend analysis. ESMO IASLC Conf 2010 Abstract 172 2010, Ref Type: Abstract.
27. Bentzen S.M., Saunders M.I., Dische S., Parmar M.K. Updated data for CHART in NSCLC: further analysis. Radiother Oncol 2000, 55:86-87.
28. Audisio R.A., Zbar A.P., Jaklitsch M.T. Surgical management of oncogeriatric patients. J Clin Oncol 2007, 25:1924-1929.
29. Yan T.D., Black D., Bannon P.G., McCaughan B.C. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 2009, 27:2553-2562.
30. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help: a SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008, 65:156-163.
31. Kates M., Perez X., Gribetz J., Swanson S.J., McGinn T., Wisnivesky J.P. Validation of a model to predict perioperative mortality from lung cancer resection in the elderly. Am J Respir Crit Care Med 2009, 179:390-395.
32. Sterling T.D., Rosenbaum W.L., Weinkam J.J. Bias in the attribution of lung cancer as cause of death and its possible consequences for calculating smoking-related risks. Epidemiology 1992, 3:11-16.